The pathogenesis of MS is unknown; apoptotic and osteogenic processes involving osteoprotegerin and receptor activator of nuclear factor-κΒ ligand (RANKL) system have been proposed as potential pathogenetic factors (Schoppet et al. 2004). Here, TNFRSF11B is linked to myeloid sarcoma.